X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (72) 72
cardiac & cardiovascular systems (65) 65
humans (63) 63
index medicus (63) 63
abridged index medicus (45) 45
mortality (42) 42
female (41) 41
male (39) 39
heart failure (36) 36
aged (32) 32
cardiac arrhythmia (27) 27
heart attacks (27) 27
heart (26) 26
middle aged (26) 26
cardiology (24) 24
atrial fibrillation (23) 23
defibrillators (23) 23
implantable cardioverter-defibrillator (22) 22
cardiovascular disease (21) 21
internal medicine (21) 21
implants, artificial (20) 20
prosthesis (20) 20
sudden cardiac death (20) 20
death, sudden, cardiac - prevention & control (19) 19
risk factors (18) 18
care and treatment (17) 17
drug therapy (17) 17
patients (17) 17
medicare (16) 16
risk assessment (16) 16
article (15) 15
hospitals (15) 15
prevention (15) 15
united states (15) 15
cardiology and cardiovascular medicine (14) 14
catheter ablation (14) 14
clinical trials (14) 14
heart beat (14) 14
heart-failure (14) 14
medical colleges (14) 14
treatment outcome (14) 14
united states - epidemiology (14) 14
analysis (13) 13
cardiac patients (13) 13
clinical medicine (13) 13
defibrillators, implantable (13) 13
heart failure - therapy (13) 13
therapy (13) 13
electrocardiography (12) 12
guidelines (12) 12
medical research (12) 12
medicine, experimental (12) 12
outcomes (12) 12
registries (12) 12
stroke (12) 12
acc/aha clinical practice guidelines (11) 11
follow-up studies (11) 11
hypertension (11) 11
aged, 80 and over (10) 10
cardiomyopathy (10) 10
death (10) 10
myocardial-infarction (10) 10
primary prevention (10) 10
risk (10) 10
cardiac arrest (9) 9
death, sudden, cardiac - epidemiology (9) 9
electric countershock (9) 9
hospitalization (9) 9
registry (9) 9
studies (9) 9
survival (9) 9
task forces (9) 9
warfarin (9) 9
anticoagulants (8) 8
cardiac resynchronization therapy (8) 8
comorbidity (8) 8
retrospective studies (8) 8
accessory atrioventricular bundle (7) 7
amiodarone (7) 7
anti-arrhythmia agents - therapeutic use (7) 7
atrial fibrillation - drug therapy (7) 7
confidence intervals (7) 7
coronary artery disease (7) 7
coronary heart disease (7) 7
disease (7) 7
heart failure - mortality (7) 7
incidence (7) 7
management (7) 7
medicine (7) 7
myocardial infarction (7) 7
quality management (7) 7
sects (7) 7
tachycardia (7) 7
ventricle (7) 7
acute coronary syndrome (6) 6
anticoagulants - therapeutic use (6) 6
arrhythmias (6) 6
clinical outcomes (6) 6
complications (6) 6
follow-up (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heart Rhythm, ISSN 1547-5271, 2015, Volume 12, Issue 10, pp. 2094 - 2095
Journal Article
Cardiac Electrophysiology Clinics, ISSN 1877-9182, 2015, Volume 7, Issue 3, pp. 497 - 513
An implantable-cardioverter defibrillator (ICD) can terminate ventricular arrhythmias by delivering a shock or by antitachycardia pacing (ATP). The ATP works... 
Cardiovascular | Ventricular tachycardia | Antitachycardia pacing | Sudden cardiac death | Implantable cardioverter-defibrillator | Ventricular fibrillation | Tachycardia, Ventricular - therapy | Defibrillators, Implantable | Humans | Middle Aged | Adult | Death | Female | Male | Aged | Ventricular Fibrillation - therapy | Cardiac Pacing, Artificial
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2008, Volume 101, Issue 8, pp. 1134 - 1141
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | WARFARIN | ANTITHROMBOTIC THERAPY | PREVENTION | RISK | HEPARIN | ASPIRIN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2016, Volume 152, Issue 5, pp. 1243 - 1275
Journal Article
Heart Rhythm, ISSN 1547-5271, 2013, Volume 10, Issue 4, pp. e59 - e65
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 64, Issue 1, pp. 32 - 39
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 23, pp. 2618 - 2629
Abstract Background Patients with moderate-to-severe chronic kidney disease (CKD) are poorly represented in clinical trials of cardiac resynchronization... 
Cardiovascular | Internal Medicine | chronic kidney disease | pacemaker | cardiomyopathy | biventricular | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | RENAL-FUNCTION | CARDIAC-RESYNCHRONIZATION THERAPY | Cardiac Resynchronization Therapy - methods | United States - epidemiology | Humans | Medicare - statistics & numerical data | Hospitalization - statistics & numerical data | Male | Electric Countershock - statistics & numerical data | Renal Insufficiency, Chronic - epidemiology | Heart Failure - therapy | Comparative Effectiveness Research | Aged, 80 and over | Female | Renal Insufficiency, Chronic - diagnosis | Heart Failure - diagnosis | Heart Failure - epidemiology | Electric Countershock - methods | Severity of Illness Index | Glomerular Filtration Rate | Comorbidity | Defibrillators, Implantable - statistics & numerical data | Proportional Hazards Models | Cardiac Resynchronization Therapy - statistics & numerical data | Treatment Outcome | Electric Countershock - instrumentation | Survival Analysis | Aged | Heart | Sects | Medical colleges | Heart beat | Chronic kidney failure | Defibrillators | Cardiovascular agents | Medical research | Implants, Artificial | Prosthesis | Medicine, Experimental | Development and progression | Comparative analysis | Confidence intervals | Heart failure | Codes | Medicare | Diagnosis related groups--DRGs | Mortality | Ulcers | Amputation | Population | Hospitalization | Kidney diseases | Dementia
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 171, Issue 1, pp. 25 - 32
Journal Article